FRANCIS REYNOLDS Insider Trading $NVIV INVIVO THERAPEUTICS HOLDINGS CORP.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for FRANCIS REYNOLDS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of FRANCIS REYNOLDS. FRANCIS REYNOLDS is CEO, CFO in INVIVO THERAPEUTICS HOLDINGS CORP. ($NVIV).
FRANCIS REYNOLDS in INVIVO THERAPEUTICS HOLDINGS CORP.
Trading Symbol: NVIVIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of FRANCIS REYNOLDS: CEO, CFO
Holdings: 14,377,660 shares
Current Value: $63,980,587
Latest Transaction: Apr 11 2012
$NVIV Market Capitalization: $139.34M
$NVIV Previous Close: $4.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of FRANCIS REYNOLDS in INVIVO THERAPEUTICS HOLDINGS CORP.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 11 2012 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | CEO, CFO | Sell | S | 2.21 | 105,000 | 232,523 | 14,377,660 | 14.5 M to 14.4 M (-0.73 %) |
Apr 11 2012 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | CEO, CFO | Sell | S | 2.29 | 165,000 | 378,345 | 14,482,660 | 14.6 M to 14.5 M (-1.13 %) |
Mar 06 2012 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | CEO, CFO | Option Exercise | A | 2.68 | 590,000 | 1,581,200 | 590,000 | |
Jan 06 2012 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | CEO, CFO | Sell | S | 2.53 | 96,503 | 244,375 | 14,647,660 | 14.7 M to 14.6 M (-0.65 %) |
Jan 06 2012 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | CEO, CFO | Sell | S | 2.63 | 109,000 | 286,779 | 14,744,163 | 14.9 M to 14.7 M (-0.73 %) |
Jan 06 2012 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | CEO, CFO | Sell | S | 2.62 | 44,497 | 116,791 | 14,853,163 | 14.9 M to 14.9 M (-0.30 %) |
Jan 03 2012 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | CEO, CFO | Sell | S | 2.70 | 11,500 | 31,050 | 14,897,660 | 14.9 M to 14.9 M (-0.08 %) |
Dec 30 2011 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | CEO, CFO | Sell | S | 2.52 | 95,000 | 239,020 | 14,909,160 | 15 M to 14.9 M (-0.63 %) |
Dec 30 2011 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | CEO, CFO | Sell | S | 2.74 | 143,500 | 392,645 | 15,004,160 | 15.1 M to 15 M (-0.95 %) |
Mar 17 2011 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | CEO, CFO | Option Exercise | A | 1.20 | 250,000 | 300,000 | 250,000 |
Page: 1